Cure My Disease

Don't miss your cure!

 Log in / Sign up

New minimally invasive spine surgery could spare patients metal implants

NCT ID NCT06995300

Symptom relief Sponsor: N.N. Priorov National Medical Research Center of Traumatology and Orthopedics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial tests a minimally invasive surgery for cervical spinal stenosis, a condition where the spinal canal narrows and presses on the spinal cord. Instead of the standard approach that uses metal screws and rods, surgeons will only remove the tissue causing the compression through a small incision in the back. The study includes 30 adults with symptoms lasting at least three months, and will measure changes in spinal canal space and symptom improvement over three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
minimally invasive decompression surgery via the posterior approach
What this could lead to
If successful, this could offer a less traumatic surgical option for cervical spinal stenosis, reducing recovery time and avoiding complications from metal implants.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. Surgery always carries risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Over 18 years old; 2. Degenerative symptomatic cervical stenosis caused by posterior compression (hypertrophied ligament flavum and/or hypertrophied facet joints etc.) confirmed by MRI; 3. Symptoms persisting for at least 3 months prior to surgery; 4. Planned surgical decompression for one and more cervical level; 5. Given written Informed Consent; 6. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements. Exclusion Criteria: 1. The need for anterior cervical decompression; 2. Prior cervical fusion at any level; 3. Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol; 4. Neck or non-radicular pain of unknown etiology; 5. History or presence of any other major neurological disease or condition that may interfere with the study assessments; 6. Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical degenerative disc disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical disk degenerative disorder spinal stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical degenerative disc disease Cervical stenosis Posterior spine surgery

Contacts and locations

Locations

  • Priorov National Medical Research Center of Traumatology and Orthopedics

    Moscow, 127299, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.